Cytek Biosciences (CTKB) Non-cash Items (2020 - 2023)

Cytek Biosciences (CTKB) has 4 years of Non-cash Items data on file, last reported at $24.1 million in Q2 2023.

• For the quarter ending Q2 2023, Non-cash Items rose 626.53% year-over-year to $24.1 million; the trailing twelve-month figure through Jun 2023 stood at $24.1 million (up 626.53% YoY), and the FY2022 full-year result was $4.2 million, up 32.5% from the prior year.
• Non-cash Items for Q2 2023 stood at $24.1 million, down from $30.9 million in the prior quarter.
• Across five years, Non-cash Items topped out at $63.9 billion in Q3 2022 and bottomed at $1.0 million in Q2 2020.
• The 4-year median for Non-cash Items is $17.8 million (2020), against an average of $5.3 billion.
• Peak annual rise in Non-cash Items reached 149515.94% in 2022, while the deepest fall reached 74.8% in 2022.
• A 4-year view of Non-cash Items shows it stood at $11.4 million in 2020, then jumped by 1194.37% to $147.6 million in 2021, then slumped by 74.8% to $37.2 million in 2022, then slumped by 35.2% to $24.1 million in 2023.
• The last three Non-cash Items figures came in at $24.1 million (Q2 2023), $30.9 million (Q1 2023), and $37.2 million (Q4 2022), per Business Quant data.

Peer Comparison